Concepedia

Publication | Open Access

Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma

126

Citations

19

References

2016

Year

Abstract

Increased risk for cutaneous squamous cell carcinomas after vismodegib therapy highlights the importance of continued skin surveillance after initiation of this therapy.

References

YearCitations

Page 1